[Apropos of sublingual specific immunotherapy].
Sabbah
A
A
D000286:Administration, Sublingual; D000485:Allergens / Q000008:administration & dosage* / Q000276:immunology; D000818:Animals; D039741:Antigens, Dermatophagoides; D002986:Clinical Trials as Topic; D003233:Conjunctivitis, Allergic / Q000276:immunology / Q000628:therapy; D016207:Cytokines / Q000502:physiology; D003888:Desensitization, Immunologic / Q000379:methods*; D004311:Double-Blind Method; D006023:Glycoproteins / Q000008:administration & dosage / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007073:Immunoglobulin E / Q000276:immunology; D018799:Intercellular Adhesion Molecule-1 / Q000032:analysis; D008925:Mites / Q000276:immunology; D009092:Mucous Membrane / Q000276:immunology; D006109:Poaceae; D011058:Pollen / Q000276:immunology; D012130:Respiratory Hypersensitivity / Q000276:immunology / Q000628:therapy*; D012221:Rhinitis, Allergic, Perennial / Q000276:immunology / Q000628:therapy; D016176:T-Lymphocyte Subsets / Q000276:immunology
D000485:Allergens; D039741:Antigens, Dermatophagoides; D016207:Cytokines; D006023:Glycoproteins; D018799:Intercellular Adhesion Molecule-1; D007073:Immunoglobulin E
A propos de l'immunothérapie spécifique sublinguale.